Markets
← Back to Stocks
CNC
CENTENE CORP
Health Care · Managed Health Care
$35.55
-1.97%
Vol: 0.1M
Araverus Market Read
Thursday, March 19, 2026
Centene stock retreats further in pre-market after earnings disappointment but maintains strong 2026 guidance with 40% EPS growth target.
CNC pre-market trading at $35.10, down 0.46% from previous session weakness. Q4 2025 beat on revenue ($49.73B vs $48.39B forecast) but stock fell 7.25% pre-market after earnings. Company projects 2026 premium/service revenue $170-174B with EPS exceeding $3.00, representing 40% YoY growth from 2025's $2.08.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$17.5B
P/E (TTM)—
Forward P/E8.7
Beta0.46
Div Yield—
Prev Close$36.26
RSI (14-Day)
21Oversold
0305070100
52-Week Range
$25.08$35.55$66.03
From High-46.2%
From Low+41.7%
Moving Averages
50d SMA
$42.12-15.6%
200d SMA
$38.03-6.5%
Price below 200d MA — bearish structure.
Returns
1W
+2.8%
1M
-17.5%
3M
-8.8%
6M
+11.0%
1Y
-40.4%
YTD
-14.9%
Volume
Today129K
20d Avg6.0M
Ratio0.02x